Aquestive Therapeutics, Inc.
Pharmaceutical & medical device company payment data from CMS Open Payments.
Total Payments
$5.2M
Doctors Paid
1,926
Transactions
8,110
2024 Total
$5,489
Payment Breakdown by Category
Research$4.3M (83.3%)
Consulting$173,340 (3.3%)
Food & Beverage$144,731 (2.8%)
Travel$67,163 (1.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $4.3M | 457 | 83.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $473,740 | 328 | 9.1% |
| Consulting Fee | $173,340 | 159 | 3.3% |
| Food and Beverage | $144,731 | 6,703 | 2.8% |
| Travel and Lodging | $67,163 | 459 | 1.3% |
| Grant | $3,000 | 2 | 0.1% |
| Honoraria | $2,925 | 1 | 0.1% |
| Education | $1,250 | 1 | 0.0% |
Payments by Type
Research
$4.3M
457 transactions
General
$866,148
7,653 transactions
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| SAFETY AND TOLERABILITY STUDY OF DIAZEPAM BUCCAL SOLUBLE FILM DBSF IN SUBJECTS WITH EPILEPSY | $875,397 | 0 | 81 |
| A PHASE 1, OPEN-LABEL, PARTIALLY RANDOMIZED ADAPTIVE DOSING CROSSOVER STUDY TO COMPARE THE PHARMACOKINETICS AND PHARMACODYNAMICS OF EPINEPHRINE FOLLOWING ADMINISTRATION OF TWO FORMULATIONS OF DIPIVEFRIN SUBLINGUAL FILM AND EPINEPHRINE ADMINISTERED AS INTRA | $332,909 | 1 | 3 |
| Safety and Tolerability Study of Diazepam Buccal Soluble Film (DBSF) in Subjects With Epilepsy (DBSF) | $295,043 | 0 | 83 |
| A RANDOMIZED, OPEN-LABEL, TWO-SEQUENCE, TWO-PERIOD, TWO-TREATMENT CROSSOVER STUDY TO EVALUATE THE EFFECT OF FOOD ON THE PHARMACOKINETICS OF VALTOCO DIAZEPAM NASAL SPRAY IN HEALTHY ADULT SUBJECTS | $230,576 | 1 | 7 |
| Study to Assess the Pharmacokinetics and Safety of DBSF in Adult Subjects With Epilepsy | $191,936 | 1 | 26 |
| UNDERSTANDING PATIENT PERCEPTIONS AND PREFERENCES FOR DIFFERENT ROUTES OF ADMINISTRATION FOR CLUSTER SEIZURE TREATMENT | $168,495 | 1 | 15 |
| AN OPEN-LABEL, SAFETY AND TOLERABILITY STUDY OF CHRONIC INTERMITTENT USE OF DIAZEPAM BUCCAL FILM DBF IN PEDIATRIC, ADOLESCENT AND ADULT SUBJECTS WITH EPILEPSY | $137,050 | 1 | 13 |
| A MULTICENTER, OPEN-LABEL, CROSSOVER STUDY TO ASSESS THE PHARMACOKINETICS AND SAFETY OF DIAZEPAM BUCCAL FILM DBF IN PEDIATRIC SUBJECTS WITH EPILEPSY | $127,997 | 1 | 14 |
| Assessment of Pharmacokinetics and Safety of Diazepam Buccal Soluble Film in Pediatric Patients (DBSF) | $110,646 | 0 | 23 |
| ASSESSMENT OF PHARMACOKINETICS AND SAFETY OF DIAZEPAM BUCCAL SOLUBLE FILM IN PEDIATRIC PATIENTS DBSF | $93,858 | 0 | 18 |
| ASSESSMENT OF PHARMACOKINETICS AND SAFETY OF DIAZEPAM BUCCAL SOLUBLE FILM IN PEDIATRIC PATIENTS | $74,525 | 0 | 13 |
| SAFETY AND TOLERABILITY STUDY OF DIAZEPAM BUCCAL SOLUBLE FILM DBSF IN SUBJECTS WITH EPILEPSY DBSF | $19,246 | 0 | 6 |
| STUDY OF DIAZEPAM BUCCAL FILM ADMINISTERED IN THE INTERICTAL AND IN THE ICTAL-PERIICTAL STATES TO ADULTS WITH EPILEPSY | $13,571 | 0 | 3 |
Payments by Medical Specialty
Top Paid Doctors — Page 2
| Doctor | Specialty | Location | Total | 2024 |
|---|---|---|---|---|
| Robert Nahouraii, Md, MD | Pediatrics | Concord, NC | $13,296 | $0 |
| Steve Chung, M.d, M.D | Neurology | Phoenix, AZ | $10,992 | $0 |
| Steven Wolf, Md, MD | Neurology | New York, NY | $10,652 | $0 |
| Eric Kossoff, M.d, M.D | Neurology | Baltimore, MD | $9,240 | $0 |
| Dr. Monika Ummat, M.d, M.D | Pediatrics | Houston, TX | $8,407 | $0 |
| Syndi Seinfeld, Do, DO | Neurology with Special Qualifications in Child Neurology | Hollywood, FL | $7,803 | $0 |
| Selim Benbadis, Md, MD | Neurology | Tampa, FL | $7,650 | $0 |
| Bilal Choudry, M.d, M.D | Epilepsy | Carlsbad, CA | $7,320 | $0 |
| Dr. Satish Agadi, Md, MD | Neurology with Special Qualifications in Child Neurology | Galveston, TX | $7,221 | $0 |
| Dr. Katherine Labiner, Md, MD | Epilepsy | Austin, TX | $6,903 | $0 |
| Dr. Dawn Eliashiv, M.d, M.D | Neurology | Los Angeles, CA | $6,752 | $0 |
| Juliann Paolicchi, Md, MD | Neurodevelopmental Disabilities | Hackensack, NJ | $6,618 | $0 |
| Patricia Penovich, Md, MD | Neurology | Saint Paul, MN | $6,168 | $0 |
| Natasha Acosta Diaz, M.d, M.D | Neurology | Lumberton, NC | $6,017 | $0 |
| Dr. John Baker, M.d, M.D | Student in an Organized Health Care Education/Training Program | Sumter, SC | $5,965 | $0 |
| David King-Stephens, M.d, M.D | Neurology | Orange, CA | $5,824 | $0 |
| Patricia Mcgoldrick, Np, NP | Nurse Practitioner | New York, NY | $5,472 | $0 |
| Kamil Detyniecki, M.d, M.D | Neurology | Miami, FL | $4,909 | $0 |
| Dr. Eric Segal, M.d, M.D | Neurodevelopmental Disabilities | N White Plains, NY | $4,761 | $0 |
| Dr. Mary Zupanc, Md, MD | Neurology | Madison, WI | $4,731 | $0 |
| Dr. Ruchi Gupta, Md Mph, MD MPH | Pediatrics | Chicago, IL | $4,537 | $0 |
| Camilo Garcia Gracia, M.d, M.D | Neurology | Weston, FL | $4,425 | $0 |
| John Oppenheimer, M.d, M.D | Internal Medicine | Sag Harbor, NY | $4,331 | $0 |
| Dr. Muhammad Zafar, M.d, M.D | Pediatrics | Durham, NC | $4,300 | $0 |
| Dr. Jay Lieberman, M.d, M.D | Allergy | Memphis, TN | $4,262 | $0 |
About Aquestive Therapeutics, Inc.
Aquestive Therapeutics, Inc. has made $5.2M in payments to 1,926 healthcare providers, recorded across 8,110 transactions in the CMS Open Payments database. In 2024, the company paid $5,489. The top product by payment volume is LIBERVANT ($1.5M).
Payments were distributed across 89 medical specialties. The top specialty by payment amount is Internal Medicine ($1.1M to 48 doctors).
Payment categories include: Food & Beverage ($144,731), Consulting ($173,340), Research ($4.3M), Travel & Lodging ($67,163).
Aquestive Therapeutics, Inc. is associated with 3 products in the CMS Open Payments database.